Welcome by ERS President N. Siafakas (Heraklion, Greece)
| |
HRCT in the diagnosis of diffuse lung disease - overlap issues D. Hansell (London, United Kingdom)
| |
Histological diagnosis in diffuse lung disease - how pathologists think A. Nicholson (London, United Kingdom)
| |
The clinican's dilemma - when is biopsy required? V. Poletti (Forli, Italy)
| |
Prognostic evaluation of idiopathic interstitial pneumonia: emerging data A. Wells (London, United Kingdom)
| |
Prognostic evaluation in connective tissue disease: a pragmatic algorithm V. Cottin (Lyon, France)
| |
Bronchoalvolar Lavage (BAL) in diffuse lung disease: Pros & Cons C. Robalo Cordeiro (Coimbra, Portugal)
| |
The diagnosis of IPF: recommendations & rationale L. Richeldi (Modena, Italy); P. Spagnolo (Modena, Italy)
| |
The management of IPF D. Bouros (Alexandroupolis, Greece)
| |
Unresolved controversies: the unwritten pages A. Wells (London, United Kingdom)
| |
Pulmonary hypertension in Pulmonary Fibrosis: detection & treatment Z. Daniil (Larissa, Greece)
| |
Smoking and pulmonary fibrosis K. Antoniou (Heraklion, Greece)
| |
Non invasive biomarkers in the diagnostic and prognostic evaluation of Pulmonary Fibrosis S. Loukides (Athens, Greece)
| |
IPF and lung cancer: what are the links? V. Poletti (Forli, Italy)
| |
Pulmonary fibrosis: ongoing trials and future treatment V. Cottin (Lyon, France)
| |
Is TGFb a central mediator in the development of pulmonary fibrosis? G. Jenkins (Nottingham, United Kingdom), A. Tatler (Nottingham, United Kingdom)
| |
Phospholipid homeostasis and IPF pathogenesis V. Aidinis (Vari, Greece)
| |
Oxidant/Antioxidant imbalance: a potential contributor to pulmonary fibrosis J. Behr (Munich, Germany)
| |
Epithelial mesenchymal transition M. Keane (Dublin, Ireland)
| |
The current classification of the idiopathic interstitial pneumonias: has it advanced pathogenetic understanding O. Eickelberg (Munich, Germany)
| |
A plethora of pathways, a medley of mediators: how do we tease out pathogenesis G. Laurent (London, United Kingdom)
| |
Genetics of pulmonary fibrosis M. Petrek (Olomouc, Czech Republic)
| |
CON - Animal models: are they still useful? T. Maher (St Albans, United Kingdom)
| |